ArticleOPEN ACCESS

Correction: Ribociclib in Kombination mit endokriner Therapie verbessert Überleben von prä-/perimenopausalen Mammakarzinom-Patientinnen (Strahlentherapie und Onkologie, (2020), 196, 3, (286-288), 10.1007/s00066-019-01574-y)

Strahlentherapie und Onkologie
DOI: 10.1007/s00066-021-01779-0
0Citations
Citations of this article
N/AReaders
Mendeley users who have this article in their library.

This article is free to access.

Cite

CITATION STYLE

APA

Krug, D., Fabian, A., & Dunst, J. (2021, July 1). Correction: Ribociclib in Kombination mit endokriner Therapie verbessert Überleben von prä-/perimenopausalen Mammakarzinom-Patientinnen (Strahlentherapie und Onkologie, (2020), 196, 3, (286-288), 10.1007/s00066-019-01574-y). Strahlentherapie Und Onkologie. Springer Science and Business Media Deutschland GmbH. https://doi.org/10.1007/s00066-021-01779-0

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free